AlveoGene
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
46 Woodstock Rd, Oxford, Oxfordshire, OX...Website
www.alveogene.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About AlveoGene
Founded in 2001 and headquartered in Oxford, UK, AlveoGene is a respiratory disease gene therapy development company.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AlveoGene your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when AlveoGene launches new products
AlveoGene, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if AlveoGene had a recent Job posting/layoffs
Earning: See what the market has to say on AlveoGene recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at AlveoGene
Check out if AlveoGene is spiking on competitors!
Funding: Get notified immidiatlly once AlveoGene has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if AlveoGene has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to AlveoGene
Compare insights from companies similar to AlveoGene, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
AlveoGene
<$5M
11-50
Private
-
2001
N/A
Company Profile Activity
Activity Insights
AlveoGene is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AlveoGene is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AlveoGene.
AlveoGene Tech Stack
A closer look at the technologies used by AlveoGene
See more technologies
AlveoGene News & Media
AlveoGene Receives Rare Pediatric Disease Designation (RPDD) from FDA for AVG-002, its Novel, Inhaled Gene Therapy for Lethal Neonatal Surfactant Protein B (SP-B) Deficiency
Oxford, UK – 15th November 2024 – AlveoGene (or ‘the Company’, www.alveogene.com), a company focused on transforming rare respiratory disease outcomes using inhaled gene therapy, announces that it has been granted a Rare Pediatric Disease Designation (RPDD) by the US Food & Drug Administration (FDA) for AVG-002, its novel inhaled gene therapy for lethal neonatal Surfactant Protein B (SP-B) deficiency.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding AlveoGene
Sign Up For FreeTo access detailed company insights
Founded in 2001 and headquartered in Oxford, UK, AlveoGene is a respiratory disease gene therapy development company.... Read More
